Assessment of hepatic functional regeneration after hepatectomy using 99mTc-GSA SPECT/CT fused imaging
Creators
- 1. Kumamoto University, Graduate School of Life Sciences, Kumamoto (Japan)
- 2. Kumamoto University, Faculty of Life Sciences, Kumamoto (Japan)
Description
The liver itself regenerates after hepatectomy but little is known about how much hepatic function recovers during the regeneration. The liver uptake value (LUV), calculated from Tc-99m-labeled galactosyl-human-serum-albumin (99mTc-GSA) SPECT/CT fused images, is reliable and useful for evaluating hepatic function. In this study, we evaluated the clinical usefulness of LUV for estimating hepatic functional regeneration after hepatectomy. We enrolled 95 patients who had undergone 99mTc-GSA SPECT/CT tests before/on days 30 and 90 after hepatectomy. We determined the LUV from the 99mTc-GSA SPECT/CT images and calculated the %LUV (post-operative LUV/preoperative LUV x 100). Based on surgical procedures and histopathological damage, we divided the study population into patients with severe (n=12) or non-severe fibrosis (n=33) who had undergone minor hepatectomy, and patients with severe (n=14) or non-severe fibrosis (n=36) having major hepatectomy. On the 90th post-hepatectomy day, five patients manifested liver failure; in these patients, we analyzed the co-relation between liver failure and the results of the liver function tests performed on day 30 after surgery. Although the %LUV reached 95.4 ± 12.2% in 30 days, in patients with severe fibrosis after major hepatectomy it remained below 90%. Patients having low %LUV (< 75%) and high serum bilirubin (> 2.0 mg/dl) at 30 days showed a relative risk of liver failure of 12.0 and 4.5 (p < 0.001 and p < 0.001), respectively. Although the %LUV recovered to about 95% in all patients within 30 days after the hepatectomy, in patients with severe fibrosis having major hepatectomy, the process of recovery was delayed. The %LUV corresponded to the quality of the liver function which emerged in a later post-hepatectomy phase. (author)
Availability note (English)
Available from http://dx.doi.org/10.1007/s12149-014-0872-3Additional details
Identifiers
Publishing Information
- Journal Title
- Annals of Nuclear Medicine
- Journal Volume
- 28
- Journal Issue
- 8
- Journal Page Range
- p. 780-788
- ISSN
- 0914-7187
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 46090070
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ALBUMINS; BILIRUBIN; BIOLOGICAL FUNCTIONS; BIOLOGICAL REGENERATION; COMPUTERIZED TOMOGRAPHY; FIBROSIS; HEPATECTOMY; HEPATOMAS; LIVER; PATIENTS; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TECHNETIUM 99; TIME-SERIES ANALYSIS; UPTAKE
- Descriptors DEC
- AZOLES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BIOLOGICAL RECOVERY; BODY; CARBOXYLIC ACIDS; CARCINOMAS; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; EMISSION COMPUTED TOMOGRAPHY; GLANDS; HETEROCYCLIC ACIDS; HETEROCYCLIC COMPOUNDS; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; MATHEMATICS; MEDICINE; NEOPLASMS; NUCLEI; ODD-EVEN NUCLEI; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; PIGMENTS; PROTEINS; PYRROLES; RADIOISOTOPES; STATISTICS; SURGERY; TECHNETIUM ISOTOPES; TOMOGRAPHY; YEARS LIVING RADIOISOTOPES